Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Alpha Adrenergic Involvement in Heart Metabolism: Effects on Adenosine Cyclic 3',5'-Monophosphate, Adenosine Cyclic 3',5'-Monophosphate-Dependent Protein Kinase, Guanosine Cyclic 3',5'-Monophosphate, and Glucose Transport

STANLEY L. KEELY, JACKIE D. CORBIN and THOMAS LINCOLN
Molecular Pharmacology September 1977, 13 (5) 965-975;
STANLEY L. KEELY
Department of Physiology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JACKIE D. CORBIN
Department of Physiology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THOMAS LINCOLN
Department of Physiology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In the perfused rat heart the alpha adrenergic agonist phenylephrine, at concentrations of 0.1-50 µM, increased the adenosine cyclic 3',5'-monophosphate (cAMP)-dependent protein kinase activity ratio in a dose-dependent manner. In all cases there was a corresponding increase in glycogen phosphorylase activity. When phenylephrine concentrations greater than 1 µM were used, there was a significant increase in cAMP associated with the rise in protein kinase activity; however, the modest increase in kinase activity produced by concentrations less than 1 µM was not accompanied by any detectable increase in cAMP. The beta adrenergic blocking agent propranolol did not inhibit activation of the cAMP-dependent protein kinase in hearts treated with low concentrations (1 µM or less) of phenylephrine, but did reduce the greater activation seen in hearts treated with higher concentrations (5 µM or more) of the drug. Phentolamine (1 µM), an alpha adrenergic blocking agent, was found to potentiate the effect of phenylephrine concentrations greater than 5 µM. When animals were treated with reserpine 18 hr prior to death, activation of cAMP-dependent protein kinase by phenylephrine was still evident. The phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine potentiated the effect of phenylephrine on all parameters measured. Calcium was necessary for the activation of protein kinase by low (1 µM or less) but not high (5 µM or greater) concentrations of the drug. Although 1 µM phenylephrine produced a slight activation of heart protein kinase when used alone, it reduced the ability of beta adrenergic agonists (e.g., isoproterenol) to activate the enzyme. Epinephrine, which has both alpha and beta adrenergic components, was a more effective activator of heart cAMP-dependent protein kinase when its alpha component was blocked with phentolamine than when epinephrine was used alone. These observations indicate that kinase activation is principally through a beta adrenergic mechanism. Epinephrine also increased glucose transport by a process which was blocked by phentolamine but not propranolol. Phenylephrine, in the presence of 3-isobutyl-1-methylxanthine, significantly increased guanosine cyclic 3',5'-monophosphate levels. This increase was blocked by the alpha antagonist phentolamine but not by the beta antagonist propranolol.

  • Copyright © 1977 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 13, Issue 5
1 Sep 1977
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Alpha Adrenergic Involvement in Heart Metabolism: Effects on Adenosine Cyclic 3',5'-Monophosphate, Adenosine Cyclic 3',5'-Monophosphate-Dependent Protein Kinase, Guanosine Cyclic 3',5'-Monophosphate, and Glucose Transport
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Alpha Adrenergic Involvement in Heart Metabolism: Effects on Adenosine Cyclic 3',5'-Monophosphate, Adenosine Cyclic 3',5'-Monophosphate-Dependent Protein Kinase, Guanosine Cyclic 3',5'-Monophosphate, and Glucose Transport

STANLEY L. KEELY, JACKIE D. CORBIN and THOMAS LINCOLN
Molecular Pharmacology September 1, 1977, 13 (5) 965-975;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Alpha Adrenergic Involvement in Heart Metabolism: Effects on Adenosine Cyclic 3',5'-Monophosphate, Adenosine Cyclic 3',5'-Monophosphate-Dependent Protein Kinase, Guanosine Cyclic 3',5'-Monophosphate, and Glucose Transport

STANLEY L. KEELY, JACKIE D. CORBIN and THOMAS LINCOLN
Molecular Pharmacology September 1, 1977, 13 (5) 965-975;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antimicrobial and Antileukemic Transportan 10 Conjugates
  • Pharmacological characterization of zebrafish H1 receptor
  • Bhave and Forman
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics